$ACAD Headlines This tiny mutual fund is no. 1 f
Post# of 145134
Posted On: 01/10/2014 3:52:27 PM
$ACAD Headlines
This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
Charting the S&P 500’s break to all-time highs 11:47 a.m. Aug. 6, 2013 - Michael Ashbaugh
Longer-term technical risk points higher 11:32 a.m. Aug. 6, 2013 - Michael Ashbaugh
7 gut checks before the stock market's opening bell 5:56 a.m. July 30, 2013 - Shawn Langlois
Charting a strong third-quarter start 11:23 a.m. July 16, 2013 - Michael Ashbaugh
Charting a strong third-quarter start 11:17 a.m. July 16, 2013 - Michael Ashbaugh
Looking for the choicest opportunity 12:37 p.m. June 11, 2013 - The Trading Deck
Declines often spell opportunity 1:11 p.m. June 6, 2013 - The Trading Deck
Don't fight the tape 10:27 a.m. May 28, 2013 - The Trading Deck
Charting the S&P’s uptrend, and its next hurdle 10:55 a.m. April 23, 2013 - Michael Ashbaugh
Charting the S&P’s uptrend, and its next hurdle 10:25 a.m. April 23, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Dow, S&P pull in from record highs 10:15 a.m. April 12, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 11:01 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 10:50 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 vies for record closing high 11:19 a.m. March 28, 2013 - Michael Ashbaugh
Acadia Pharma up 10% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi
Acadia slides as SA article paints grim picture 12:39 p.m. Jan. 7, 2014 - Seeking Alpha
Healthcare Stocks To Avoid This Year 10:08 a.m. Jan. 7, 2014 - Seeking Alpha
4 Stocks That Could See Significant Gains In 2014 2:35 p.m. Jan. 6, 2014 - Seeking Alpha
Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days 11:52 a.m. Jan. 6, 2014 - Seeking Alpha
A Tiny-Stock Fund Is No. 1 for 2013 4:28 p.m. Jan. 5, 2014 - WSJ.com
Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV 5:59 p.m. Jan. 2, 2014 - Investors Business Daily
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Taking A Look At A Few Of The Top Performers Of 2013 12:27 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Acadia: The Best Hope For Parkinson's Psychosis Sufferers 4:21 p.m. Dec. 27, 2013 - Seeking Alpha
ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Health Care Laggard 5:01 p.m. Dec. 26, 2013 - TheStreet.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
Understanding The Investment Opportunity In Developmental Biotechnology 6:31 p.m. Dec. 11, 2013 - Seeking Alpha
Lessons Learned From The Top 20 Stocks Of 2013 4:44 p.m. Dec. 11, 2013 - Seeking Alpha
ACADIA Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference (Transcript) 2:06 p.m. Dec. 10, 2013 - Seeking Alpha
2013's Top Performers 6:56 p.m. Dec. 9, 2013 - Seeking Alpha
ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Drugs Winner 5:01 p.m. Dec. 4, 2013 - TheStreet.com
Why Acadia Is A Promising Investment 1:17 p.m. Dec. 4, 2013 - Seeking Alpha
ACADIA Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 3:18 p.m. Dec. 3, 2013 - Seeking Alpha
ACADIA Pharmaceuticals (ACAD) Highlighted As Today's Perilous Reversal Stock 10:00 a.m. Dec. 3, 2013 - TheStreet.com
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch 8:00 a.m. Dec. 25, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola 8:00 a.m. Nov. 29, 2013 - PR Newswire
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 26, 2013 - BusinessWire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Earnings, Trend Analysis: The Dow Chemical, Turquoise Hill Resources, ACADIA Pharmaceuticals, E Commerce China Dangdang, Yum! Brands 9:35 a.m. Nov. 15, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis 9:00 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:28 a.m. Nov. 7, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:01 p.m. Nov. 6, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin 8:40 p.m. Oct. 31, 2013 - BusinessWire
Under The Radar Big Pharma Partnership Opportunity for Zalicus,Targacept and ACADIA 5:16 a.m. Oct. 31, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013 9:00 a.m. Oct. 30, 2013 - BusinessWire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 9:00 a.m. Oct. 29, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 9:05 a.m. Oct. 21, 2013 - PR Newswire
Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver 9:31 a.m. Oct. 16, 2013 - PR Newswire
Reveal Insider Trading for Opko Health, ACADIA Pharmaceuticals, Synaptics, Intel, Charles Schwab, and Molycorp 8:55 a.m. Oct. 16, 2013 - PR Newswire
This tiny mutual fund is no. 1 for 2013 7:33 a.m. Jan. 7, 2014 - Suzanne McGee
Despite Fed concerns, technicals support bull case 1:16 p.m. Sept. 17, 2013 - Michael Ashbaugh
Despite Fed concerns, technicals support bull case 12:02 p.m. Sept. 17, 2013 - Michael Ashbaugh
A bull market not ready to be put to rest 11:14 a.m. Sept. 5, 2013 - The Trading Deck
Charting the S&P 500’s break to all-time highs 11:47 a.m. Aug. 6, 2013 - Michael Ashbaugh
Longer-term technical risk points higher 11:32 a.m. Aug. 6, 2013 - Michael Ashbaugh
7 gut checks before the stock market's opening bell 5:56 a.m. July 30, 2013 - Shawn Langlois
Charting a strong third-quarter start 11:23 a.m. July 16, 2013 - Michael Ashbaugh
Charting a strong third-quarter start 11:17 a.m. July 16, 2013 - Michael Ashbaugh
Looking for the choicest opportunity 12:37 p.m. June 11, 2013 - The Trading Deck
Declines often spell opportunity 1:11 p.m. June 6, 2013 - The Trading Deck
Don't fight the tape 10:27 a.m. May 28, 2013 - The Trading Deck
Charting the S&P’s uptrend, and its next hurdle 10:55 a.m. April 23, 2013 - Michael Ashbaugh
Charting the S&P’s uptrend, and its next hurdle 10:25 a.m. April 23, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 1:33 p.m. April 17, 2013 - The Trading Deck
Dow, S&P pull in from record highs 10:15 a.m. April 12, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 11:01 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 chips away at all-time highs 10:50 a.m. April 9, 2013 - Michael Ashbaugh
S&P 500 vies for record closing high 11:19 a.m. March 28, 2013 - Michael Ashbaugh
Acadia Pharma up 10% in premarket 9:17 a.m. Dec. 12, 2012 - Steve Gelsi
Acadia slides as SA article paints grim picture 12:39 p.m. Jan. 7, 2014 - Seeking Alpha
Healthcare Stocks To Avoid This Year 10:08 a.m. Jan. 7, 2014 - Seeking Alpha
4 Stocks That Could See Significant Gains In 2014 2:35 p.m. Jan. 6, 2014 - Seeking Alpha
Acadia Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days 11:52 a.m. Jan. 6, 2014 - Seeking Alpha
A Tiny-Stock Fund Is No. 1 for 2013 4:28 p.m. Jan. 5, 2014 - WSJ.com
Top Stocks Of 2013 Run Gamut: Solar, Drugs, Tech, TV 5:59 p.m. Jan. 2, 2014 - Investors Business Daily
Biotech 2013 By The Numbers: A Blockbuster Year 9:13 a.m. Jan. 1, 2014 - TheStreet.com
Taking A Look At A Few Of The Top Performers Of 2013 12:27 p.m. Dec. 30, 2013 - Seeking Alpha
The Billion-Dollar Biotech Club: Speculation Trumped Risk 9:19 a.m. Dec. 30, 2013 - TheStreet.com
Acadia: The Best Hope For Parkinson's Psychosis Sufferers 4:21 p.m. Dec. 27, 2013 - Seeking Alpha
ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Health Care Laggard 5:01 p.m. Dec. 26, 2013 - TheStreet.com
Following Smart Money: Baker Brothers LLC Investments In 2013 And Beyond 8:01 a.m. Dec. 19, 2013 - Seeking Alpha
Understanding The Investment Opportunity In Developmental Biotechnology 6:31 p.m. Dec. 11, 2013 - Seeking Alpha
Lessons Learned From The Top 20 Stocks Of 2013 4:44 p.m. Dec. 11, 2013 - Seeking Alpha
ACADIA Pharmaceuticals' CEO Presents at Oppenheimer 24th Annual Healthcare Conference (Transcript) 2:06 p.m. Dec. 10, 2013 - Seeking Alpha
2013's Top Performers 6:56 p.m. Dec. 9, 2013 - Seeking Alpha
ACADIA Pharmaceuticals Inc. (ACAD): Today's Featured Drugs Winner 5:01 p.m. Dec. 4, 2013 - TheStreet.com
Why Acadia Is A Promising Investment 1:17 p.m. Dec. 4, 2013 - Seeking Alpha
ACADIA Pharmaceuticals' CEO Presents at 25th Annual Piper Jaffray Healthcare Conference (Transcript) 3:18 p.m. Dec. 3, 2013 - Seeking Alpha
ACADIA Pharmaceuticals (ACAD) Highlighted As Today's Perilous Reversal Stock 10:00 a.m. Dec. 3, 2013 - TheStreet.com
Biotech Industry Stock Update: Cell Therapeutics, Sarepta Therapeutics, ACADIA Pharma, and Medivation 8:00 a.m. Jan. 2, 2014 - PR Newswire
Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch 8:00 a.m. Dec. 25, 2013 - PR Newswire
Breakfast Technical Briefing: Sarepta Therapeutics, ACADIA Pharma, Cell Therapeutics, and Medivation 11:23 a.m. Dec. 6, 2013 - PR Newswire
Proposed M&A's, Conference Schedules, Health Awareness Programs, Prestigious Recognitions and FDA Designations - Research Report on Health Management, Acadia, Health Net, NuVasive and Portola 8:00 a.m. Nov. 29, 2013 - PR Newswire
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences 9:00 a.m. Nov. 26, 2013 - BusinessWire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Earnings, Trend Analysis: The Dow Chemical, Turquoise Hill Resources, ACADIA Pharmaceuticals, E Commerce China Dangdang, Yum! Brands 9:35 a.m. Nov. 15, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Initiation of Phase II Trial with Pimavanserin for Alzheimer's Disease Psychosis 9:00 a.m. Nov. 14, 2013 - BusinessWire
Financial Results, Conference Presentations, Stock Price Update, and Warrant Exercises - Research Report on Halozyme Therapeutics, Oxygen Biotherapeutics, ACADIA, MannKind, and ViroPharma 8:00 a.m. Nov. 13, 2013 - PR Newswire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
ACAD, CRTX, MACK and NVAX added to NASDAQ Healthcare Stock Watch List at EPR 9:28 a.m. Nov. 7, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals Reports Third Quarter 2013 Financial Results 4:01 p.m. Nov. 6, 2013 - BusinessWire
Clinical Trial Data, New Publications, Promotions, Financial Results and FDA Acknowledgements - Research Report on Gilead, Amgen, ACADIA Pharmaceuticals, ViroPharma, and MannKind 8:00 a.m. Nov. 6, 2013 - PR Newswire
ACADIA Pharmaceuticals Announces Publication in The Lancet of Pivotal Phase III Parkinson's Disease Psychosis Trial with Pimavanserin 8:40 p.m. Oct. 31, 2013 - BusinessWire
Under The Radar Big Pharma Partnership Opportunity for Zalicus,Targacept and ACADIA 5:16 a.m. Oct. 31, 2013 - ACCESSWIRE
ACADIA Pharmaceuticals to Announce Third Quarter 2013 Financial Results on November 6, 2013 9:00 a.m. Oct. 30, 2013 - BusinessWire
Financial Results & Release Schedules, Stock Performance Update, and New Clinical Trials - Research Report on Amgen, Boston Scientific, ACADIA Pharmaceuticals, Seattle Genetics, and Volcano 9:00 a.m. Oct. 29, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 9:05 a.m. Oct. 21, 2013 - PR Newswire
Critical Alerts For SunPower, Starbucks, ACADIA Pharmaceuticals, Opko Health, and Cytokinetics Released By InvestorsObserver 9:31 a.m. Oct. 16, 2013 - PR Newswire
Reveal Insider Trading for Opko Health, ACADIA Pharmaceuticals, Synaptics, Intel, Charles Schwab, and Molycorp 8:55 a.m. Oct. 16, 2013 - PR Newswire
(0)
(0)